ArticleFrontiers in oncology2023

Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates.

Ye-Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.